Continent Let Down By Aids Drug Firms - GSK Chief
The CEO of drug giant GlaxoSmithKline (GSK), Jean-Pierre Garnier, says the international pharmaceuticals industry has been too slow in addressing the HIV/AIDS pandemic, especially in Africa.

While defending GSK's policy on AIDS treatment he said Glaxo and its competitors could have acted sooner by taking the initiative to supply cheap drugs to Africa.

In a recent interview with British newspaper, The Times, Garnier said: "We should have done it way before anybody knew there was a problem in Africa. We, I, didn't have the vision of saying, 'we must act now'."

Garnier accused the industry of having been dominated for too long by 'techies in white coats'.